Abstract
. In contrast to ESCs, mesenchymal stem cells (MSCs) (endoderm, mesoderm, ectoderm) and have challenged the restrictive differentiation potential of somatic stem cells [6] . A convenient and recently explored source of MSCs is adipose tissue-derived stem cells (ASCs) purified from liposuction material [7, 8] . Like bone marrow-derived MSCs, ASCs can differentiate into mesodermal cell types; however, recent findings suggest a limited differentiation ability even within mesodermal lineages [9, 10] .
So although MSCs retain the ability of express various lineage-specific genes upon differentiation, this potential is clearly more restricted than in ESCs.
Increasing (Fig. 1A) . CpG methylation is symmetrical-it occurs on both DNA strands (Fig. 1B) [17] [18] [19] [20] [21] , but has been shown to have cytoplasmic transfer RNA methyltransferase activity [22, 23] .
DNA methylation is a hallmark of long-term gene silencing (Fig. 1C) . The methyl groups create target sites for methyl-binding proteins which induce transcriptional repression by recruiting co-repressors, such as histone deacetylases [24] . So DNA methylation largely contributes to gene silencing [25, 26] and as such it is essential for development [27] [28] [29] [30] , X chromosome inactivation [31] and genomic imprinting [32] [33] [34] [35] . The relationship between DNA methylation and gene expression is complex [36] [9, 10, 41, 42] . [48] . In contrast, we found that human ASCs undergo stochastic methylation changes upon culture [9, 10] [51] [52] [53] . [54] . Although distinct from tumour suppressor CpG island methylation, this hypermethylation leads to the down-regulation of the affected genes, and as such has been suggested to have implications in the development of metabolic diseases [54] . Thus, the risk of aberrant CpG island methylation upon hESC differentiation should be considered when optimizing differentiation protocols, in particular for therapeutic purposes.
CpG methylation profiles in mouse ESCs

(see below). So the hypothesis of programmed CpG methylation changes during culture may not necessarily hold for cell types other than hESCs. Several reports on random methylation events in human cell cultures supports this view
Another issue is whether unscheduled CpG methylation occurs upon in vitro differentiation of hESCs. Analysis of over 4,600 CpG islands revealed that 65 (1.4%) undergo unexpected hypermethylation upon neurogenic differentiation of hESCs, in regulatory regions of genes involved in metabolism, signal transduction and differentiation
With the exception of a handful of genes, methylation patterns in the human EC cell line NTERA2 are globally similar to those of ESCs [46] . Our own work also illustrates the hypomethylated state of the OCT4 promoter and enhancer regions, the NANOG upstream region [40] [37, 55] . Such data can be superimposed onto transcription factor binding [37, 55] Fig. 2A and B) . In particular, di-and trimethylation of H3 lysine 9 (H3K9m2/m3) and trimethylation of H3K27 (H3K27m3) elicit the formation of repressive heterochromatin through the recruitment of heterochromatin protein 1 (HP1) [60] and polycomb group (PcG) proteins, respectively [61] [62] [63] . However, whereas H3K9m3 marks constitutive heterochromatin [64] , H3K27m3 characterizes facultative heterochromatin, or chromatin domains harbouring transcriptionally repressed genes that can be activated upon ad hoc stimulation [65, 66] [74] (Fig. 3A) [65, 66] (Fig. 4A) . Azuara et al. [65] 
Polycomb group proteins impose a transcriptional brake on lineage-priming genes
PcGs are transcriptional repressors [81, 82] found within two distinct and conserved PRCs (PRC1 and PCR2) working co-operatively [83] .
Involvement of PRCs in pluripotency has been suggested by the requirement of PcG proteins for the patterning of gene expression during development, for establishing pluripotent ESCs and for maintaining somatic stem cell cultures (reviewed in [84]).
In undifferentiated ESCs, PcGs preferentially (but not exclusively) occupy genes that are activated upon differentiation, consistent with the view that these genes are poised for transcription [85] [86] [87] (Fig. 4B) . Histone methyltransferase activity of Eed and enhancer of zeste homologue 2 (Ezh2; another PRC2 component) is responsible for trimethylation of H3K27 on these target genes [61, 62] . In addition, trimethylation of H3K4 is mediated by Trithorax group (Trx) proteins [82] [74] . differentiation, PcGs are displaced from promoters [87] . Furthermore [87] . This program would mark certain genes for transcriptional repression upon differentiation, while other genes would be primed for activation (Fig. 4B ).
. Thus, the known interplay between PcG and Trx proteins is also likely to establish bivalent histone modifications on developmentally regulated genes in pluripotent cells. PcGs, however, are also dynamic and not always associated with transcriptionally repressed genes. For genes activated upon
Fig. 3 Pluripotent ESCs display greater histone mobility than differentiated cells. (A) Relative mobility of H2B-green fluorescent protein (GFP), H3-yellow fluorescent protein (YFP) and of the histone variant H3.3-YFP was determined by fluorescent recovery after photobleaching in undifferentiated mouse ESCs, in ESCs cultured for 24 hrs without leukaemia inhibitory factor (Diff. ESCs) and in neuronal progenitor cells (NPC). Relative protein mobility (or protein recovery rate after photobleaching) is indicated by the width of the coloured bar. Mobility of HP1-GFP is also reduced upon differentiation of ESCs. (B) Proportion of the mobile fraction of H2B-GFP, H3-YFP and H3.3-YFP in ESCs, differentiated ESCs and neuronal progenitor cells (NPC). Figure was drawn from data presented in
It will be interesting to determine whether genes poised for transcriptional activation or repression by PcG proteins are marked by distinct histone modifications (e.g. different levels of the active H3K9ac mark) or by a specific CpG methylation status. An increasing body of evidence, therefore, suggests that unique combinations of CpG methylation, histone modifications, PcG occupancy and nucleosome positioning [88-91] on developmentally regulated gene promoters, in a context of hyperdynamic chromatin, define a pluripotent genomic organization in ESCs.
The epigenetic makeup of mesenchymal stem cells reflects restricted differentiation potential
The interplay between epigenetic modifications and potential for gene activation in ESCs is being unravelled, however, the picture remains largely incomplete when it comes to somatic stem cells. This section highlights recent published and unpublished findings on the relationship between DNA methylation of lineage-specification genes, gene expression and potential for cell differentiation in MSCs, with a focus on ASCs from which most epigenetic analyses have been reported. A concept emerging from these studies is that a CpG methylation pattern pre-programs ASCs for differentiation into adipocytes preferentially over other cell types.
CpG methylation patterns on lineage-specific promoters in adipose stem cells
Adipose tissue harbours an abundant source of MSCs [7, 8, 92, 93] [41, 92] [87] . (Fig. 5A and B [14, [100] [101] [102] [103] , together with a propensity of certain CpGs to be hypermethylated [52, 104] . Indeed, each locus examined in ASCs displays CpGs that are preferentially susceptible to methylation [10] .
Recent studies have begun to unravel the CpG methylation profile of a number of tissue-specific genes in human ASCs
In contrast to adipogenic promoters, however, myogenic or endothelial cell regulatory regions display significantly more methylation [9, 10] (Fig. 5B) [10] . Conversely, hypermethylation does not preclude expression, as exemplified by transcription of the methylated CD31 and CD144 loci in ASCs [9] (see also below). Thus, gene expression in ASCs does not correlate with a specific methylation pattern in any of the genes examined thus far. This observation is not restricted to pluripotent cells [36, 105] .
CpG content affects the relationship between promoter DNA methylation and transcriptional activity
Recent genome-wide DNA methylation profiling shows that the relationship between promoter DNA methylation and promoter activity depends on the CpG content of the promoter [37] . Promoters [9, 10] Linking DNA methylation to histone modifications, chromatin packaging and (re)organization of the nuclear compartment DNA methylation has long been implicated in the organization of the nuclear compartment, particularly in regions of constitutive heterochromatin (see [108] for an overview of the evidence). A recent study shed light on the nature of the relationship between global DNA methylation levels and chromatin organization [108] (Fig. 7A) [108] (Fig. 7A) [109] (Fig. 7B) [65] . Genes that are not needed, however, replicate later in S phase. Indeed, genes encoding key neuronal-specific transcription factors replicate early in undifferentiated ESCs, but late in haematopoietic stem cells in which these genes are not required [65] . Therefore, lineage-specification genes are able to undergo modifications in chromatin organization and switch from early to late replication timing in the course of differentiation.
Early replication timing has been linked to enriched histone acetylation [112, 113] [116] together with improved bioinformatics tools will enhance the resolution of the current stem cell epigenetic map.
Secondly, a largely unexplored area is in vivo epigenetics [9, 10] [73, 74, [117] [118] [119] [120] [121] [122] [123] , fusion with ESCs [124] [125] [126] , treatment with extracts from eggs [127] , ESCs or other pluripotent cells [40] and retroviral transduction of pluripotency-associated factors [128] . These approaches have been recently reviewed [129, 130] 
